Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try

키워드

참고문헌 (20)

1. Fan JG, "New trends on obesity and NAFLD in Asia", J Hepatol, 67, pp.862~873 (2017)
2. Friedman SL, "Mechanisms of NAFLD development and therapeutic strategies", Nat Med, 24, pp.908~922 (2018)
3. Oh H, "Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment", Clin Mol Hepatol, 22, pp.327~335 (2016)
4. Byrne CD, "NAFLD: a multisystem disease", J Hepatol, 62(1 Suppl), pp.S47~64 (2015)
5. Zhang X, "New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD)", Protein Cell, 9, pp.164~177 (2018)
6. Zhou D, "Microbial metabolites in non-alcoholic fatty liver disease", World J Gastroenterol, 25, pp.2019~2028 (2019)
7. Canfora EE, "Gut microbial metabolites in obesity, NAFLD and T2DM", Nat Rev Endocrinol, 15, pp.261~273 (2019)
8. Jena PK, "Synbiotics Bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone nonalcoholic steatohepatitis using western diet-fed FXR knockout mouse models", J Nutr Biochem, 57, pp.246~254 (2018)
9. Park SS, "Lactobacillus acidophilus NS1 attenuates diet-induced obesity and fatty liver", J Endocrinol, 237, pp.87~100 (2018)
10. Kim B, "Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice", PLoS One, 13, pp.e0210120~ (2018)
11. Xiao MW, "Systematic review with meta-analysis: the effects of probiotics in nonalcoholic fatty liver disease", Gastroenterol Res Pract, 2019, pp.1484598~ (2019)
12. Duseja A, "High potency multistrain probiotic improves liver histology in nonalcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study", BMJ Open Gastroenterol, 6, pp.e000315~ (2019)
13. Famouri F, "Effects of probiotics on nonalcoholic fatty liver disease in obese children and adolescents", J Pediatr Gastroenterol Nutr, 64, pp.413~417 (2017)
14. Shavakhi A, "Effect of a probiotic and metformin on liver aminotransferases in non-alcoholic steatohepatitis: a double blind randomized clinical trial", Int J Prev Med, 4, pp.531~537 (2013)
15. Ahn SB, "Randomized, double-blind, placebo-controlled study of a multispecies probiotic mixture in nonalcoholic fatty liver disease", Sci Rep, 9, pp.5688~ (2019)
16. Na Young Lee, "Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis", Clinical and Molecular Hepatology, 27(1), pp.110~124 (2021), 대한간학회[DOI]
17. Eslam M, "International Consensus Panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease", Gastroenterology, 158, pp.1999~2014.e1 (2020)
18. Eslam M, "A new definition for metabolic dysfunctionassociated fatty liver disease: an international expert consensus statement", J Hepatol, 73, pp.202~209 (2020)
19. Vallianou N, "Probiotics, prebiotics, synbiotics, postbiotics, and obesity: current evidence, controversies, and perspectives", Curr Obes Rep, 9, pp.179~192 (2020)
20. Tenorio-Jiménez C, "Effects of probiotics on metabolic syndrome: a systematic review of randomized clinical trials", Nutrients, 12, pp.124~ (2020)

관련 논문AI추천